What blocks more anticancer platinum complexes from experiment to clinic: Major problems and potential strategies from drug design perspectives
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
What blocks more anticancer platinum complexes from experiment to clinic: Major problems and potential strategies from drug design perspectives
Authors
Keywords
Anticancer platinum complexes, Drug resistance, Toxic side effects, Targeted therapy, Immune response
Journal
COORDINATION CHEMISTRY REVIEWS
Volume 449, Issue -, Pages 214210
Publisher
Elsevier BV
Online
2021-09-15
DOI
10.1016/j.ccr.2021.214210
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Strategy for Traceless Codrug Delivery with Platinum(IV) Prodrug Complexes Using Self-Immolative Linkers
- (2021) Violet Eng Yee Lee et al. INORGANIC CHEMISTRY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Selectivity and Targeting of G‐quadruplex Binders Activated by Adaptive Binding and Controlled by Chemical Kinetics
- (2021) Bo-Chen Zhu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end?
- (2021) Dan Gibson JOURNAL OF INORGANIC BIOCHEMISTRY
- A Multiaction and Multitarget Ru(II)-Pt(IV) Conjugate Combining Cancer Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers
- (2020) Johannes Karges et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A Gold(I) Complex Containing an Oleanolic Acid Derivative as a Potential Anti‐ovarian Cancer Agent via Inhibiting TrxR and Activating ROS‐mediated ERS
- (2020) Wukun Liu et al. CHEMISTRY-A EUROPEAN JOURNAL
- Content Detection of G‐Quadruplex DNA in Live Cells Based on Photon Counts and Complex Structures
- (2020) Liu-Yi Liu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Recent advances in endoplasmic reticulum targeting metal complexes
- (2020) Can Huang et al. COORDINATION CHEMISTRY REVIEWS
- Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors
- (2020) Sabrina Dallavalle et al. DRUG RESISTANCE UPDATES
- How We Think about Targeting RNA with Small Molecules
- (2020) Matthew G. Costales et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Photocaged, Water-Oxidizing, and Nucleolus-Targeted Pt(IV) Complex with a Distinct Anticancer Mechanism
- (2020) Zhiqin Deng et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Oxaliplatin Pt(IV) prodrugs conjugated to gadolinium-texaphyrin as potential antitumor agents
- (2020) Grégory Thiabaud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multiple‐Color Platinum Complex with Super‐Large Stokes Shift for Super‐Resolution Imaging of Autolysosome Escape
- (2020) Liu-Yi Liu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- CAIXplatins: Highly Potent Platinum(IV) Prodrugs Selective Against Carbonic Anhydrase IX for the Treatment of Hypoxic Tumors
- (2020) Qian Cao et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- PlatinER: a Highly Potent Anticancer Platinum(II) Complex that induces Endoplasmic Reticulum Stress‐driven Immunogenic Cell Death
- (2020) Max Jing Rui Tham et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- How promising is phototherapy for cancer?
- (2020) Huayun Shi et al. BRITISH JOURNAL OF CANCER
- Challenges and Opportunities in Cancer Drug Resistance
- (2020) Richard A. Ward et al. CHEMICAL REVIEWS
- Multispecific Platinum(IV) Complex Deters Breast Cancer via Interposing Inflammation and Immunosuppression as an Inhibitor of COX‐2 and PD‐L1
- (2020) Suxing Jin et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Multiaction Platinum(IV) Prodrug Containing Thymidylate Synthase Inhibitor and Metabolic Modifier against Triple-Negative Breast Cancer
- (2020) Nafees Muhammad et al. INORGANIC CHEMISTRY
- Pt(IV) pro-drugs with an axial HDAC inhibitor demonstrate multimodal mechanisms involving DNA damage and apoptosis independent of cisplatin resistance in A2780/A2780cis cells
- (2020) Awatif Rashed Z. Almotairy et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Platinum-Based Combination Therapy: Molecular Rationale, Current Clinical Uses, and Future Perspectives
- (2020) Chunqiu Yu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Platinum(IV) antitumor complexes and their nano-drug delivery
- (2020) Chunyan Jia et al. COORDINATION CHEMISTRY REVIEWS
- Construction of Dual Stimuli-Responsive Platinum(IV) Hybrids with NQO1 Targeting Ability and Overcoming Cisplatin Resistance
- (2019) Lei Fang et al. INORGANIC CHEMISTRY
- Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer
- (2019) Maurizio Sabbatini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pt(IV) hybrids containing a TDO inhibitor serve as potential anticancer Immunomodulators
- (2019) Shixian Hua et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Restraining Cancer Cells by Dual Metabolic Inhibition with a Mitochondrion-Targeted Platinum(II) Complex
- (2019) Kun Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Dual-Targeting Dual-Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity
- (2019) Maria V. Babak et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Substitution-Inert Polynuclear Platinum Complexes with Dangling Amines: Condensation/Aggregation of Nucleic Acids and Inhibition of DNA-Related Enzymatic Activities
- (2019) Jaroslav Malina et al. INORGANIC CHEMISTRY
- A cisplatin-based platinum(IV) prodrug containing a glutathione s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer
- (2019) Hong Chen et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Development of a series of 4-hydroxycoumarin platinum(IV) hybrids as antitumor agents: Synthesis, biological evaluation and action mechanism investigation
- (2019) Guoshuai Li et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- A Subset of New Platinum Antitumor Agents Kills Cells by a Multimodal Mechanism of Action Also Involving Changes in the Organization of the Microtubule Cytoskeleton
- (2019) Hana Kostrhunova et al. JOURNAL OF MEDICINAL CHEMISTRY
- TriplatinNC and Biomolecules: Building Models Based on Non-covalent Interactions
- (2019) Nathália M. P. Rosa et al. Frontiers in Chemistry
- An Antitumor Bis(N-Heterocyclic Carbene)Platinum(II) Complex That Engages Asparagine Synthetase as an Anticancer Target
- (2019) Di Hu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- New designs for phototherapeutic transition metal complexes
- (2019) Peter J. Sadler et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Photoactivated Lysosomal Escape of a Monofunctional PtII Complex Pt-BDPA for Nucleus Access
- (2019) Xuling Xue et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A view on multi-action Pt(IV) antitumor prodrugs
- (2019) Mauro Ravera et al. INORGANICA CHIMICA ACTA
- Synthesis and Cytotoxic Study of a Platinum(IV) Anticancer Prodrug with Selectivity toward Luteinizing Hormone-Releasing Hormone (LHRH) Receptor-Positive Cancer Cells
- (2019) Houzong Yao et al. INORGANIC CHEMISTRY
- Enhancing Cytotoxicity of a Monofunctional Platinum Complex via a Dual-DNA-Damage Approach
- (2019) Yan Guo et al. INORGANIC CHEMISTRY
- Expanding the Arsenal of PtIV Anticancer Agents: Multi-action PtIV Anticancer Agents with Bioactive Ligands Possessing a Hydroxy Functional Group
- (2019) Thirumal Yempala et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- N-Heterocyclic Carbene Platinum Complexes: A Big Step Forward for Effective Antitumor Compounds
- (2019) Stéphane Bellemin-Laponnaz EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
- Synthesis, Cytotoxicity, and Mechanistic Investigation of Platinum(IV) Anticancer Complexes Conjugated with Poly(ADP-ribose) Polymerase Inhibitors
- (2019) Zoufeng Xu et al. INORGANIC CHEMISTRY
- Phorbiplatin, a Highly Potent Pt(IV) Antitumor Prodrug That Can Be Controllably Activated by Red Light
- (2019) Zhigang Wang et al. Chem
- Substitution-Inert Polynuclear Platinum Complexes That Inhibit the Activity of DNA Polymerase in Triplex-Forming Templates
- (2018) Jaroslav Malina et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Engineering functional inorganic–organic hybrid systems: advances in siRNA therapeutics
- (2018) Jianliang Shen et al. CHEMICAL SOCIETY REVIEWS
- Development of an Efficient Dual-Action GST-Inhibiting Anticancer Platinum(IV) Prodrug
- (2018) Keefe Guang Zhi Lee et al. ChemMedChem
- The cisplatin-based Pt(iv)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions
- (2018) Elisabetta Gabano et al. DALTON TRANSACTIONS
- The side effects of platinum-based chemotherapy drugs: a review for chemists
- (2018) Rabbab Oun et al. DALTON TRANSACTIONS
- Mitochondria-targeted platinum(II) complexes induce apoptosis-dependent autophagic cell death mediated by ER-stress in A549 cancer cells
- (2018) Feng-Yang Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A Potential Bone-Targeting Hypotoxic Platinum(II) Complex with an Unusual Cytostatic Mechanism toward Osteosarcoma Cells
- (2018) Zhenqin Zhang et al. INORGANIC CHEMISTRY
- Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance
- (2018) Emanuele Petruzzella et al. Chemical Science
- Photodamaging Mitochondrial DNA to Overcome Cisplatin Resistance by a Ru(II)-Pt(II) Bimetallic Complex
- (2018) Yue Zheng et al. CHEMISTRY-A EUROPEAN JOURNAL
- Photoactivated platinum-based anticancer drugs
- (2018) Muhammad Imran et al. COORDINATION CHEMISTRY REVIEWS
- Impact of Mitochondrion-Targeting Group on the Reactivity and Cytostatic Pathway of Platinum(IV) Complexes
- (2018) Suxing Jin et al. INORGANIC CHEMISTRY
- Solution structures of multiple G-quadruplex complexes induced by a platinum(II)-based tripod reveal dynamic binding
- (2018) Wenting Liu et al. Nature Communications
- Current Developments in Pt(IV) Prodrugs Conjugated with Bioactive Ligands
- (2018) Xuejiao Li et al. BIOINORGANIC CHEMISTRY AND APPLICATIONS
- Stimuli-Responsive Therapeutic Metallodrugs
- (2018) Xiaohui Wang et al. CHEMICAL REVIEWS
- Metal Drugs and the Anticancer Immune Response
- (2018) Bernhard Englinger et al. CHEMICAL REVIEWS
- Photoactivatable Cell-Selective Dinuclear trans-Diazidoplatinum(IV) Anticancer Prodrugs
- (2018) Huayun Shi et al. INORGANIC CHEMISTRY
- Multi-action Pt(IV) anticancer agents; do we understand how they work?
- (2018) Dan Gibson JOURNAL OF INORGANIC BIOCHEMISTRY
- Platinum iodido complexes: A comprehensive overview of anticancer activity and mechanisms of action
- (2018) Pavel Štarha et al. COORDINATION CHEMISTRY REVIEWS
- Platinum(IV) Prodrugs - A Step Closer to Ehrlich's Vision?
- (2017) Reece G. Kenny et al. EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
- Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy
- (2017) Yuichi Tambo et al. INVESTIGATIONAL NEW DRUGS
- Antitumor platinum(IV) derivatives of carboplatin and the histone deacetylase inhibitor 4-phenylbutyric acid
- (2017) Awatif Rashed Z. Almotairy et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- G-quadruplex DNA targeted metal complexes acting as potential anticancer drugs
- (2017) Qian Cao et al. Inorganic Chemistry Frontiers
- Platinum Group Metal Compounds in Cancer Chemotherapy
- (2017) Christopher Barnard Johnson Matthey Technology Review
- Platinum coordination compounds with potent anticancer activity
- (2017) Krishant M. Deo et al. COORDINATION CHEMISTRY REVIEWS
- Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator
- (2016) Gregory Thiabaud et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance
- (2016) Zhigang Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Platinum-based drugs: past, present and future
- (2016) Shahana Dilruba et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer
- (2016) Weimin Wang et al. CELL
- Trigeminal star-like platinum complexes induce cancer cell senescence through quadruplex-mediated telomere dysfunction
- (2016) Xiao-Hui Zheng et al. CHEMICAL COMMUNICATIONS
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
- (2016) Timothy C. Johnstone et al. CHEMICAL REVIEWS
- Monofunctional Platinum (PtII) Compounds – Shifting the Paradigm in Designing New Pt-based Anticancer Agents
- (2016) Shu Xian Chong et al. CURRENT MEDICINAL CHEMISTRY
- Platinum(iv) anticancer prodrugs – hypotheses and facts
- (2016) Dan Gibson DALTON TRANSACTIONS
- Platinum complexes as light promoted anticancer agents: a redefined strategy for controlled activation
- (2016) Koushambi Mitra DALTON TRANSACTIONS
- Behavior of platinum(iv) complexes in models of tumor hypoxia: cytotoxicity, compound distribution and accumulation
- (2016) Ekaterina Schreiber-Brynzak et al. Metallomics
- E platinum, a newly synthesized platinum compound, induces apoptosis through ROS-triggered ER stress in gastric carcinoma cells
- (2016) Xiaoping Wang et al. MOLECULAR CARCINOGENESIS
- Insights into RNA binding by the anticancer drug cisplatin from the crystal structure of cisplatin-modified ribosome
- (2016) Sergey V. Melnikov et al. NUCLEIC ACIDS RESEARCH
- Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action
- (2016) Raji Raveendran et al. Chemical Science
- Induction of Immunogenic Cell Death by Chemotherapeutic Platinum Complexes
- (2015) Daniel Yuan Qiang Wong et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells
- (2015) Vojtech Novohradsky et al. BIOCHEMICAL PHARMACOLOGY
- Chalcoplatin, a dual-targeting and p53 activator-containing anticancer platinum(iv) prodrug with unique mode of action
- (2015) Lili Ma et al. CHEMICAL COMMUNICATIONS
- Multi-platinum anti-cancer agents. Substitution-inert compounds for tumor selectivity and new targets
- (2015) N. P. Farrell CHEMICAL SOCIETY REVIEWS
- Platinum(ii) clovers targeting G-quadruplexes and their anticancer activities
- (2015) Xiao-Hui Zheng et al. DALTON TRANSACTIONS
- Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt-based anti-cancer drugs
- (2015) R. Planells-Cases et al. EMBO JOURNAL
- Carbonic anhydrase IX inhibitors in cancer therapy: an update
- (2015) Claudiu T Supuran et al. Future Medicinal Chemistry
- Improvements in the synthesis and understanding of the iodo-bridged intermediate en route to the Pt(IV) prodrug satraplatin
- (2015) Timothy C. Johnstone et al. INORGANICA CHIMICA ACTA
- A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy
- (2015) Samuel G. Awuah et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Platinum(II)-Gadolinium(III) Complexes as Potential Single-Molecular Theranostic Agents for Cancer Treatment
- (2014) Zhenzhu Zhu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Luminescent Cyclometalated Platinum(II) Complex Forms Emissive Intercalating Adducts with Double-Stranded DNA and RNA: Differential Emissions and Anticancer Activities
- (2014) Taotao Zou et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Immuno-Chemotherapeutic Platinum(IV) Prodrugs of Cisplatin as Multimodal Anticancer Agents
- (2014) Daniel Yuan Qiang Wong et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The Prodrug Platin-A: Simultaneous Release of Cisplatin and Aspirin
- (2014) Rakesh K. Pathak et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Advances in Combination Therapies Based on Nanoparticles for Efficacious Cancer Treatment: An Analytical Report
- (2014) Serge Mignani et al. BIOMACROMOLECULES
- The role of DNA repair pathways in cisplatin resistant lung cancer
- (2014) Shane O’Grady et al. CANCER TREATMENT REVIEWS
- The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells
- (2014) Qinqin Cheng et al. CHEMICAL COMMUNICATIONS
- Nanomaterials for Theranostics: Recent Advances and Future Challenges
- (2014) Eun-Kyung Lim et al. CHEMICAL REVIEWS
- Cover Picture: Photoinduced Reduction of PtIVwithin an Anti-Proliferative PtIV-Texaphyrin Conjugate (Chem. Eur. J. 29/2014)
- (2014) Grégory Thiabaud et al. CHEMISTRY-A EUROPEAN JOURNAL
- Conjugates of Cisplatin and Cyclooxygenase Inhibitors as Potent Antitumor Agents Overcoming Cisplatin Resistance
- (2014) Wilma Neumann et al. ChemMedChem
- Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands
- (2014) Vojtech Novohradsky et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery
- (2014) Yao-Rong Zheng et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Nanocarriers for delivery of platinum anticancer drugs
- (2013) Hardeep S. Oberoi et al. ADVANCED DRUG DELIVERY REVIEWS
- Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment
- (2013) E. M. Dijkgraaf et al. CANCER RESEARCH
- Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer
- (2013) Judith Michels et al. CELL CYCLE
- Luminescent organoplatinum(ii) complexes containing bis(N-heterocyclic carbene) ligands selectively target the endoplasmic reticulum and induce potent photo-toxicity
- (2013) Taotao Zou et al. CHEMICAL COMMUNICATIONS
- Can Controversial Nanotechnology Promise Drug Delivery?
- (2013) Venkat Ratnam Devadasu et al. CHEMICAL REVIEWS
- Anticancer C,N-Cycloplatinated(II) Complexes Containing Fluorinated Phosphine Ligands: Synthesis, Structural Characterization, and Biological Activity
- (2013) Natalia Cutillas et al. INORGANIC CHEMISTRY
- Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells
- (2013) Manuela Alessio et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Cisplatin, oxaliplatin, and carboplatin unequally inhibit in vitro mRNA translation
- (2013) Jonas Philipp Becker et al. TOXICOLOGY LETTERS
- A platinum anticancer theranostic agent with magnetic targeting potential derived from maghemite nanoparticles
- (2013) Jinzhuan Wang et al. Chemical Science
- Gd-DTPA-loaded polymer–metal complex micelles with high relaxivity for MR cancer imaging
- (2012) Peng Mi et al. BIOMATERIALS
- Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs
- (2012) Wukun Liu et al. CHEMICAL SOCIETY REVIEWS
- Contribution of intracellular ATP to cisplatin resistance of tumor cells
- (2012) Verena Schneider et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Conjugate of Pt(IV)–Histone Deacetylase Inhibitor as a Prodrug for Cancer Chemotherapy
- (2012) Jun Yang et al. MOLECULAR PHARMACEUTICS
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death
- (2012) L. Menger et al. Science Translational Medicine
- A texaphyrin–oxaliplatin conjugate that overcomes both pharmacologic and molecular mechanisms of cisplatin resistance in cancer cells
- (2012) Jonathan F. Arambula et al. MedChemComm
- Remarkable Potential of the α-Aminophosphonate/Phosphinate Structural Motif in Medicinal Chemistry
- (2011) Artur Mucha et al. JOURNAL OF MEDICINAL CHEMISTRY
- Site-Specific Platinum(II) Cross-Linking in a Ribozyme Active Site
- (2011) Erich G. Chapman et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- The new platinum-based anticancer agent LA-12 induces retinol binding protein 4 in vivo
- (2011) Pavel Bouchal et al. Proteome Science
- Nanoparticulate Alternatives for Drug Delivery
- (2010) James H. Adair et al. ACS Nano
- Selective Aggregation of a Platinum-Gadolinium Complex Within a Tumor-Cell Nucleus
- (2010) Ellen L. Crossley et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Visible Drug Delivery by Supramolecular Nanocarriers Directing to Single-Platformed Diagnosis and Therapy of Pancreatic Tumor Model
- (2010) S. Kaida et al. CANCER RESEARCH
- The status of platinum anticancer drugs in the clinic and in clinical trials
- (2010) Nial J. Wheate et al. DALTON TRANSACTIONS
- Targeting mitochondria for cancer therapy
- (2010) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Mechanisms of Cisplatin Nephrotoxicity
- (2010) Ronald P. Miller et al. Toxins
- A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity
- (2009) Darren Griffith et al. CHEMICAL COMMUNICATIONS
- Platinum Drug Distribution in Cancer Cells and Tumors
- (2009) Alice V. Klein et al. CHEMICAL REVIEWS
- Satraplatin: leading the new generation of oral platinum agents
- (2009) Ashish Bhargava et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Rapid Cross-Linking of an RNA Internal Loop by the Anticancer Drug Cisplatin
- (2009) Alethia A. Hostetter et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Immunogenic death of colon cancer cells treated with oxaliplatin
- (2009) A Tesniere et al. ONCOGENE
- Platinum Resistance: The Role of DNA Repair Pathways
- (2008) L. P. Martin et al. CLINICAL CANCER RESEARCH
- Transfer RNA Bindings to Antitumor Estradiol-Platinum(II) Hybrid and Cisplatin
- (2008) Christophe N. N'soukpoé-Kossi et al. DNA AND CELL BIOLOGY
- Imaging in the era of molecular oncology
- (2008) Ralph Weissleder et al. NATURE
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started